The brain-derived neurotrophic factor gene in suicidal behaviour: A meta-analysis

International Journal of Neuropsychopharmacology

Volumn 15, Issue 8, 2012, Pages 1037-1042

  Zai, Clement C ^a,b   Manchia, Mirko ^a,c,d   De Luca, Vincenzo ^a,b   Tiwari, Arun K ^a   Chowdhury, Nabilah I ^a   Zai, Gwyneth C ^a,b   Tong, Ryan P ^a   Yilmaz, Zeynep ^a   Shaikh, Sajid A ^a   Strauss, John ^a,b   Kennedy, James L ^a,b  

^a CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF CAGLIARI   (Italy)

^d DALHOUSIE UNIVERSITY   (Canada)

Author keywords

Brain derived neurotrophic factor (BDNF); genetics; meta analysis; schizophrenia; suicidal behaviour; suicide attempt

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; METHIONINE; VALINE;

ALLELE; ARTICLE; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HETEROZYGOTE; HUMAN; PRIORITY JOURNAL; SUICIDAL BEHAVIOR; SUICIDE; SUICIDE ATTEMPT;

BRAIN-DERIVED NEUROTROPHIC FACTOR; GENE FREQUENCY; GENOTYPE; HUMANS; METHIONINE; ODDS RATIO; SUICIDE; VALINE;

EID: 84864568147     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001313     Document Type: Article

References (23)

1. Bondy B, Buettner A, Zill P (2006). Genetics of suicide. Molecular Psychiatry 11, 336-351.
2. Brent D, Melhem N, Turecki G (2010). Pharmacogenomics of suicidal events. Pharmacogenomics 11, 793-807.
3. Brown S (1997). Excess mortality of schizophrenia. A meta-analysis. British Journal of Psychiatry 171, 502-508.
4. De Luca V, Souza RP, Zai CC, Panariello F, et al. (2011). Parent of origin effect and differential allelic expression of BDNF Val66Met in suicidal behaviour. World Journal of Biological Psychiatry 12, 42-47.
5. Dwivedi Y (2010). Brain-derived neurotrophic factor and suicide pathogenesis. Annals of Medicine 42, 87-96.
6. Egan MF, Kojima M, Callicott JH, Goldberg TE, et al. (2003). The BDNF val66met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112, 257-269.
7. Hong CJ, Huo SJ, Yen FC, Tung CL, et al. (2003). Association study of a brain-derived neurotrophic-factor genetic polymorphism and mood disorders, age of onset and suicidal behavior. Neuropsychobiology 48, 186-189.
8. Huang TL, Lee CT (2007). Associations between brain-derived neurotrophic factor G196A gene polymorphism and clinical phenotypes in schizophrenia patients. Chang Gung Medical Journal 30, 408-413.
9. Hwang JP, Tsai SJ, Hong CJ, Yang CH, Lirng JF, Yang YM (2006). The Val66Met polymorphism of the brain-derived neurotrophic-factor gene is associated with geriatric depression. Neurobiology of Aging 27, 1834-1837.
10. Iga J, Ueno S, Yamauchi K, Numata S, et al. (2007). The Val66Met polymorphism of the brain-derived neurotrophic factor gene is associated with psychotic feature and suicidal behavior in japanese major depressive patients. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 144B, 1003-1006.
11. Keller S, Sarchiapone M, Zarrilli F, Videtic A, et al. (2010). Increased BDNF promoter methylation in the Wernicke area of suicide subjects. Archives of General Psychiatry 67, 258-267.
12. Kim B, Kim CY, Hong JP, Kim SY, et al. (2008). Brainderived neurotrophic factor Val/Met polymorphism and bipolar disorder. Association of the met allele with suicidal behavior of bipolar patients. Neuropsychobiology 58, 97-103.
13. Kohli MA, Salyakina D, Pfennig A, Lucae S, et al. (2010). Association of genetic variants in the neurotrophic receptor-encoding gene NTRK2 and a lifetime history of suicide attempts in depressed patients. Archives of General Psychiatry 67, 348-359.
14. Lyons WE, Mamounas LA, Ricaurte GA, Coppola V, et al. (1999). Brain-derived neurotrophic factor-deficient mice develop aggressiveness and hyperphagia in conjunction with brain serotonergic abnormalities. Proceedings of the National Academy of Sciences USA 96, 15239-15244.
15. Perroud N, Aitchison KJ, Uher R, Smith R, et al. (2009). Genetic predictors of increase in suicidal ideation during antidepressant treatment in the GENDEP project. Neuropsychopharmacology 34, 2517-2528.
16. Pregelj P, Nedic G, Paska AV, Zupanc T, et al. (2011). The association between brain-derived neurotrophic factor polymorphism (BDNF Val66Met) and suicide. Journal of Affective Disorders 128, 287-290.
17. Sarchiapone M, Carli V, Roy A, Iacoviello L, et al. (2008). Association of polymorphism (Val66Met) of brain-derived neurotrophic factor with suicide attempts in depressed patients. Neuropsychobiology 57, 139-145.
18. Schmidt HD, Duman RS (2010). Peripheral BDNF produces antidepressant-like effects in cellular and behavioral models. Neuropsychopharmacology 35, 14.
19. Spalletta G, Morris DW, Angelucci F, Rubino IA, et al. (2010). BDNF Val66Met polymorphism is associated with aggressive behavior in schizophrenia. European Psychiatry 25, 311-313.
20. Vincze I, Perroud N, Buresi C, Baud P, et al. (2008). Association between brain-derived neurotrophic factor gene and a severe form of bipolar disorder, but no interaction with the serotonin transporter gene. Bipolar Disorders 10, 580-587.
21. Zai CC, Manchia M, De Luca V, Tiwari AK, et al. (2010a). Association study of BDNF and DRD3 genes in schizophrenia diagnosis using matched case-control and family based study designs. Progress in Neuro- Psychopharmacology and Biological Psychiatry 34, 1412-1418.
22. Zai CC, Tiwari AK, Muller DJ, de Luca V, et al. (2010b). The catechol-O-methyl-transferase gene in tardive dyskinesia. World Journal of Biological Psychiatry 11, 803-812.
23. Zarrilli F, Angiolillo A, Castaldo G, Chiariotti L, et al. (2009). Brain derived neurotrophic factor (BDNF) genetic polymorphism (Val66Met) in suicide: a study of 512 cases. American Journal of Medical Genetics, Part B: Neuropsychiatric Genetics 150B, 599-600.